Skip to content

Clinical trials

Scleroderma, Systemic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: Germany Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20071
20084
20101
20114
20122
20135
20142
20154
20161
20181
20191
20211
20223
20234
20243
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting9
Terminated6
Unknown status6
Active, not recruiting3
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion4
Boehringer Ingelheim4
Charite University, Berlin, Germany4
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company3
AstraZeneca2
Heidelberg University2
Hoffmann-La Roche2
ISDIN2
ARCIM Institute Academic Research in Complementary and Integrative Medicine1
Active Biotech AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic50
Scleroderma, Diffuse10
Arthritis, Rheumatoid7
Myositis7
Lung Diseases, Interstitial5
Lupus Erythematosus, Systemic5
Hypertension, Pulmonary4
Raynaud Disease4
Autoimmune Diseases3
Dermatomyositis3

Trials

Showing 51 to 50 of 50. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.